ConductScience.org, home

Paper4178641

Modification of Parkinsonism--chronic treatment with L-dopa.

Cotzias GC and 2 others. N Engl J Med, 1969. Cited by 1,249 papers, by iCite.

Cite this record

ConductScience Library. Modification of Parkinsonism--chronic treatment with L-dopa. Papers, record 4178641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4178641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Modification of Parkinsonism--chronic treatment with L-dopa.
PubMed
Journal
N Engl J Med
PubMed
Year
1969
PubMed
Publication types
Clinical Trial, Controlled Clinical Trial, Journal Article
PubMed
Citations, by iCite
1,249
iCite
Revised in PubMed
2022-04-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cotzias GCG C
2Papavasiliou PSP S
3Gellene RR

Source PubMed

Download CSV of authors

Topics27

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DihydroxyphenylalanineMajor topic
Parkinson DiseaseMajor topic
Adult
Aged
Agranulocytosis
Aromatic Amino Acid Decarboxylase Inhibitors
Blood Urea Nitrogen
Blood-Brain Barrier
Chronic Disease
Dopamine
Feeding and Eating Disorders
Female
Humans
Huntington Disease
Male
Manganese
Mental Processes
Methyldopa
Middle Aged
Movement Disorders
Nausea
Neurologic Manifestations
Phenylacetates
Placebos
Thyroid Function Tests
Tyrosine
Vomiting

Source PubMed

Download CSV of topics

Cited by306

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,249 citations.

PMIDTitleJournalYearIn PapersSource
42965636Subcutaneous apomorphine and the nonmotor features of Parkinson's disease.J Neural Transm (Vienna)2026https://conductscience.org/library/papers/42965636PubMed
42869935Perspectives on ionizing radiation and Parkinson's disease.NPJ Parkinsons Dis2026https://conductscience.org/library/papers/42869935PubMed
42646502Parkinson's Disease: Pathophysiology, Treatment Strategies, Wellness Approaches, and Obstacles/Paths Forward.NeuroSci2026https://conductscience.org/library/papers/42646502PubMed
42449370Parkinson's disease as a multi-axis systems disorder: integrating molecular pathology and circuit-level therapeutics.Cell Commun Signal2026https://conductscience.org/library/papers/42449370PubMed
42393412Cardiovascular pharmacology of dopaminergic agents in humans: a review.Clin Auton Res2026https://conductscience.org/library/papers/42393412PubMed
42205208Dopamine 2 receptor ablation from cholinergic neurons attenuates L-DOPA induced dyskinesias.Front Aging Neurosci2026https://conductscience.org/library/papers/42205208PubMed
42192052The Dark Matter of Levodopa Pharmacodynamics.Mov Disord2026https://conductscience.org/library/papers/42192052PubMed
41854085The central cholinergic system as a therapeutic target in Parkinson's disease.J Parkinsons Dis2026https://conductscience.org/library/papers/41854085PubMed
41269916Mucuna pruriens in untreated Parkinson's disease in sub-Saharan Africa: A 12-month, multicenter, randomized, controlled trial.J Parkinsons Dis2026https://conductscience.org/library/papers/41269916PubMed
41192415Dopamine production in the central nervous system is important for follicle survival and interacts with genetic background and a high sugar diet during Drosophila oogenesis.Genetics2026https://conductscience.org/library/papers/41192415PubMed
411427003D printing in medicine: bridging imaging, education, and practice.Arch Med Sci Atheroscler Dis2025https://conductscience.org/library/papers/41142700PubMed
41117498A PLAN to address the Parkinson pandemic.J Parkinsons Dis2025https://conductscience.org/library/papers/41117498PubMed
41019763Combined molecular characterization and dopa-responsive treatment in two patients with NR4A2-associated intellectual developmental disorder.Front Genet2025https://conductscience.org/library/papers/41019763PubMed
40808403Nigrostriatal dopaminergic vulnerability in Parkinson's disease: Neuroprotective strategies.Neural Regen Res2026https://conductscience.org/library/papers/40808403PubMed
40679671Update on the Present and Future Pharmacologic Treatment of Parkinson's Disease.Neurol Ther2025https://conductscience.org/library/papers/40679671PubMed
40635563Disease-Modifying Trials in Treated Parkinson's Disease: "Stable Treated" Does Not Equate with Biological Stability.Mov Disord2025https://conductscience.org/library/papers/40635563PubMed
40593919Postsynaptic adaptations in direct pathway muscarinic M4-receptor signaling follow the temporal and regional pattern of dopaminergic degeneration.NPJ Parkinsons Dis2025https://conductscience.org/library/papers/40593919PubMed
40500227Striatal Dopamine Actions and Movement: Inferences from Parkinson Disease.J Neurosci2025https://conductscience.org/library/papers/40500227PubMed
40293707L-DOPA Induces Spatially Discrete Changes in Gene Expression in the Forebrain of Mice with a Progressive Loss of Dopaminergic Neurons.Mol Neurobiol2025https://conductscience.org/library/papers/40293707PubMed
40216783Oral health implications in Parkinson's disease.NPJ Parkinsons Dis2025https://conductscience.org/library/papers/40216783PubMed

See all 306 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4178641

GET https://conductscience.org/api/papers/v1/4178641/cited_by?page=2